TD Asset Management Inc grew its position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 27.3% in the second quarter, according to its most recent filing with the SEC. The fund owned 386,366 shares of the real estate investment trust's stock after acquiring an additional 82,868 shares during the quarter. TD Asset Management Inc owned about 0.06% of Healthpeak Properties worth $6,765,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently modified their holdings of DOC. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Healthpeak Properties by 584.6% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 9,218,848 shares of the real estate investment trust's stock valued at $186,405,000 after acquiring an additional 7,872,150 shares during the last quarter. Nuveen LLC bought a new position in shares of Healthpeak Properties during the 1st quarter valued at approximately $124,113,000. Invesco Ltd. boosted its position in shares of Healthpeak Properties by 20.7% during the 1st quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust's stock valued at $467,311,000 after acquiring an additional 3,967,830 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in shares of Healthpeak Properties by 57.8% during the 1st quarter. Goldman Sachs Group Inc. now owns 6,764,854 shares of the real estate investment trust's stock valued at $136,785,000 after acquiring an additional 2,477,307 shares during the last quarter. Finally, Amundi boosted its position in shares of Healthpeak Properties by 89.4% during the 1st quarter. Amundi now owns 5,047,699 shares of the real estate investment trust's stock valued at $98,228,000 after acquiring an additional 2,382,657 shares during the last quarter. 93.57% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of research firms have recently commented on DOC. Robert W. Baird set a $21.00 target price on Healthpeak Properties and gave the company an "outperform" rating in a research report on Wednesday, July 30th. Evercore ISI set a $22.00 price target on Healthpeak Properties in a research report on Monday, September 15th. Wall Street Zen downgraded Healthpeak Properties from a "hold" rating to a "sell" rating in a research report on Monday, July 7th. Scotiabank downgraded Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and lowered their price target for the stock from $21.00 to $19.00 in a research report on Tuesday, July 29th. Finally, Wells Fargo & Company lowered their price target on Healthpeak Properties from $20.00 to $18.00 and set an "equal weight" rating for the company in a research report on Wednesday, August 27th. Eight equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $21.33.
View Our Latest Analysis on Healthpeak Properties
Healthpeak Properties Price Performance
Healthpeak Properties stock opened at $18.55 on Monday. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.28 and a quick ratio of 1.28. The firm has a 50-day moving average of $18.16 and a two-hundred day moving average of $17.89. The stock has a market cap of $12.89 billion, a price-to-earnings ratio of 77.27, a price-to-earnings-growth ratio of 3.16 and a beta of 1.09. Healthpeak Properties, Inc. has a 1 year low of $16.63 and a 1 year high of $23.26.
Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting the consensus estimate of $0.46. The firm had revenue of $694.35 million during the quarter, compared to the consensus estimate of $697.14 million. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.The firm's quarterly revenue was down .2% on a year-over-year basis. During the same period in the previous year, the company posted $0.45 earnings per share. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, research analysts forecast that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.
Healthpeak Properties Dividend Announcement
The company also recently declared a monthly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 19th will be given a dividend of $0.1017 per share. This represents a c) annualized dividend and a dividend yield of 6.6%. The ex-dividend date of this dividend is Friday, December 19th. Healthpeak Properties's dividend payout ratio is presently 508.33%.
Insider Activity at Healthpeak Properties
In other news, CEO Scott M. Brinker purchased 1,490 shares of the firm's stock in a transaction on Monday, August 4th. The stock was acquired at an average cost of $16.83 per share, with a total value of $25,076.70. Following the completion of the transaction, the chief executive officer owned 211,906 shares in the company, valued at $3,566,377.98. This represents a 0.71% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders have bought 8,783 shares of company stock worth $150,129 over the last ninety days. Corporate insiders own 0.23% of the company's stock.
Healthpeak Properties Company Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Read More
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.